Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer DOI Creative Commons
Ignacio Alfaro, Margarita Vega, Carmen Romero

и другие.

Pharmaceuticals, Год журнала: 2023, Номер 16(11), С. 1515 - 1515

Опубликована: Окт. 24, 2023

Ovarian cancer (OC) is one of the most lethal gynecological malignancies. The use biological compounds such as non-coding RNAs (ncRNAs) being considered a therapeutic option to improve or complement current treatments since deregulation ncRNAs has been implicated in pathogenesis and progression OC. Old drugs with antitumoral properties have also studied context cancer, although their antitumor mechanisms are not fully clear. For instance, antidiabetic drug metformin shown pleiotropic effects several vitro models including Interestingly, reported regulate ncRNAs, which could explain its diverse on tumor cells. In this review, we discuss mechanism epigenetic regulation described for metformin, focus evidence metformin-dependent microRNA (miRNAs) long RNA (lncRNAs)

Язык: Английский

Pharmacological Approaches to Decelerate Aging: A Promising Path DOI Open Access
Bahareh Hassani,

Ghazal Goshtasbi,

Shirin Nooraddini

и другие.

Oxidative Medicine and Cellular Longevity, Год журнала: 2022, Номер 2022, С. 1 - 25

Опубликована: Июль 11, 2022

Biological aging or senescence is a course in which cellular function decreases over period of time and consequence altered signaling mechanisms that are triggered stressed cells leading to cell damage. Aging among the principal risk factors for many chronic illnesses such as cancer, cardiovascular disorders, neurodegenerative diseases. Taking this into account, targeting fundamental therapeutically may effectively impact numerous illnesses. Selecting ideal therapeutic options order hinder process decelerate progression age-related diseases valuable. Along options, life style modifications well render aging. The affected by alteration pathways amid mTOR, SIRT1, AMPK most emphasized. Herein, we have discussed focusing mainly on mentioned role inflammation autophagy Moreover, drugs natural products with antiaging properties detail.

Язык: Английский

Процитировано

12

MiR-10b-5p Regulates Neuronal Autophagy and Apoptosis Induced by Spinal Cord Injury Through UBR7 DOI Creative Commons
Shuangmei Liu, Huali Liu,

Chunyan Gong

и другие.

Neuroscience, Год журнала: 2024, Номер 543, С. 13 - 27

Опубликована: Фев. 19, 2024

This study aimed to explore the effects of miR-10b-5p on autophagy and apoptosis in neuronal cells after spinal cord injury (SCI) molecular mechanism. Bioinformatics was used analyze differentially expressed miRNAs. The expression related genes proteins were detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) Western blot, respectively. Cell proliferation 5-ethynyl-2'-deoxyuridine (EdU), flow cytometry or terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL). Coimmunoprecipitation confirmed interaction between UBR7 Wnt1 Beclin1. Autophagy dansylcadaverine (MDC). Basso Beattie Bresnahan (BBB) score evaluate motor function, hematoxylin-eosin (H&E) Nissl staining detect tissue repair changes. result shows that downregulated SCI models, transfection a mimic inhibited cell apoptosis. MiR-10b-5p negatively regulated UBR7, inhibitory effect reversed overexpressing UBR7. In addition, can regulate affecting Wnt/β-catenin pathway promoting ubiquitination. Treatment with effectively improved apoptosis, promoted rats. Overall, alleviate downregulating expression, inhibiting signaling ubiquitination reduce Beclin 1 promote autophagy.

Язык: Английский

Процитировано

2

Dextran sulfate inhibits proliferation and metastasis of human gastric cancer cells via miR-34c-5p DOI Creative Commons

Yuan Zhao,

Qian Ma,

Wenwei Gao

и другие.

Heliyon, Год журнала: 2024, Номер 10(15), С. e34859 - e34859

Опубликована: Июль 18, 2024

Gastric cancer (GC) is a malignant tumor with high global mortality rate that currently difficult to treat. Dextran sulfate (DS), safe anti-tumor agent, can effectively inhibit the biological behavior of gastric cancer; however, its mechanism action not fully understood. Therefore, this study aimed at elucidate potential mechanisms action.

Язык: Английский

Процитировано

1

Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma DOI Creative Commons
Melika Hajimohammadebrahim-Ketabforoush, Alireza Zali, Mohammadreza Shahmohammadi

и другие.

Frontiers in Oncology, Год журнала: 2024, Номер 14

Опубликована: Авг. 29, 2024

Despite reaching enormous achievements in therapeutic approaches worldwide, GBM still remains the most incurable malignancy among various cancers. It emphasizes necessity of adjuvant therapies from perspectives both patients and healthcare providers. Therefore, emerging studies have focused on complementary therapies. Among them, metabolic therapy has received special attention, metformin been considered as a treatment types cancer, including GBM. is clearly evident that efficient without comprehensive evaluation key mechanisms not possible. studied mechanisms, one more challenging ones effect apoptosis senescence. Moreover, well known an insulin sensitizer. However, if signaling facilitated tumor microenvironment, it may result growth. to partially resolve some paradoxical issues, we conducted narrative review related address following questions comprehensively possible: 1) Does improvement cellular function resulting detrimental or beneficial effects cells? 2) If these are cells, which important: senescence? 3) What determines decision between

Язык: Английский

Процитировано

1

Non-coding RNAs as potential targets in metformin therapy for cancer DOI Creative Commons
Yihan Zhang, Yunhao Wu, Zixu Liu

и другие.

Cancer Cell International, Год журнала: 2024, Номер 24(1)

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

1

Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer DOI Creative Commons
Domenico Conza,

Paola Mirra,

Francesca Fiory

и другие.

Cells, Год журнала: 2023, Номер 12(17), С. 2182 - 2182

Опубликована: Авг. 30, 2023

The biguanide drug metformin is widely used in type 2 diabetes mellitus therapy, due to its ability decrease serum glucose levels, mainly by reducing hepatic gluconeogenesis and glycogenolysis. A considerable number of studies have shown that metformin, besides antidiabetic action, can improve other disease states, such as polycystic ovary disease, acute kidney injury, neurological disorders, cognitive impairment renal damage. In addition, well known suppress the growth progression different types cancer cells both vitro vivo. Accordingly, several epidemiological suggest capable lowering risk rate deaths among diabetic patients. antitumoral effects been proposed be mediated activation AMP-activated protein kinase (AMPK). However, a signaling pathways, dependent independent AMPK activation, reported involved action. Among these, Wingless Int pathway recently included. Here, we will focus our attention on main molecular mechanisms involved.

Язык: Английский

Процитировано

3

Metformin Reduces Repeat Mild Concussive Injury Pathophysiology DOI Creative Commons
Erica L. Underwood, John B. Redell,

Mark E. Maynard

и другие.

eNeuro, Год журнала: 2021, Номер 9(1), С. ENEURO.0421 - 21.2021

Опубликована: Дек. 13, 2021

Abstract Mild traumatic brain injury (mTBI) can initiate complex pathophysiological changes in the brain. Numerous cellular and molecular mechanisms underlying these pathologic are altered after injury, including those involved energy utilization, excitotoxicity, ionic disturbances, inflammation. It is thought that targeting multiple may be necessary to produce meaningful reductions pathology improve outcome. Previous studies have reported anti-diabetic drug metformin also affect inflammatory, cell survival, metabolic outcomes, possibly by acting on targets and/or pathways. We therefore questioned whether treatment reduce repeat mild closed head (rmCHI) male C57Bl/6 mice. found metformin, administered acutely each impact, resulted markedly reduced white matter damage, astrogliosis, loss of hippocampal parvalbumin neurons, improved mitochondrial function. In addition, both motor cognitive functions were significantly when tested discontinuation treatment. These suggest beneficial as a for concussion.

Язык: Английский

Процитировано

2

Metformin attenuates the progression of esophageal squamous cell carcinoma by downregulating miR-141-3p to enhance SCEL DOI Creative Commons
Shan Liu, Tianyou Chen,

Fengying Jie

и другие.

Archives of Medical Science, Год журнала: 2023, Номер unknown

Опубликована: Янв. 20, 2023

Introduction Metformin (Met), a first-line oral anti-type 2 diabetes medication used globally, has been shown to hinder cancer progression via regulation of microRNAs (miRNAs). The previous reports on the relationship between Met use and risk esophageal squamous cell carcinoma (ESCC) have controversial. Hence, this study aimed explore how affected ESCC underlying molecular mechanism. Material methods Cell migration, viability invasiveness were respectively investigated using wound healing, CCK-8 transwell assay. expressions miR-141-3p Sciellin (SCEL) mRNA examined by mean quantitative real-time PCR (qRT-PCR) assay, SCEL protein level was quantified western blotting. In vivo tests performed animals. predicted binding more evidenced dual-luciferase Results treatment in largely impaired viability, migration invasiveness. MiR-141-3p showed high expression downregulated cells after treatment. upregulation Met-administered restored proliferative ability, also attenuated anti-tumor effect vivo. targeted whose declined ESCC, reinforced depleted thus partially abolished anti-cancer impacts Met-treated cells. Conclusions restrains regulating miR-141-3p/SCEL axis. Our findings clearly show that is associated with lower its anticancer could potentially be treat ESCC.

Язык: Английский

Процитировано

0

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer DOI Creative Commons
Ignacio Alfaro, Margarita Vega, Carmen Romero

и другие.

Pharmaceuticals, Год журнала: 2023, Номер 16(11), С. 1515 - 1515

Опубликована: Окт. 24, 2023

Ovarian cancer (OC) is one of the most lethal gynecological malignancies. The use biological compounds such as non-coding RNAs (ncRNAs) being considered a therapeutic option to improve or complement current treatments since deregulation ncRNAs has been implicated in pathogenesis and progression OC. Old drugs with antitumoral properties have also studied context cancer, although their antitumor mechanisms are not fully clear. For instance, antidiabetic drug metformin shown pleiotropic effects several vitro models including Interestingly, reported regulate ncRNAs, which could explain its diverse on tumor cells. In this review, we discuss mechanism epigenetic regulation described for metformin, focus evidence metformin-dependent microRNA (miRNAs) long RNA (lncRNAs)

Язык: Английский

Процитировано

0